Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-09-18
2007-09-18
Shameem, Golam M. M. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S079000
Reexamination Certificate
active
11360711
ABSTRACT:
In its many embodiments, the present invention provides a novel class of compounds as inhibitors of type 3 17β-hydroxysteroid dehydrogenase, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with type 3 17β-hydroxysteroid dehydrogenase using such compounds or pharmaceutical compositions.
REFERENCES:
patent: 6162804 (2000-12-01), Bilodeau et al.
patent: 6362188 (2002-03-01), Guzi et al.
patent: 6541463 (2003-04-01), Labrie et al.
patent: 1122242 (2001-08-01), None
patent: WO86/01105 (1986-02-01), None
patent: WO 86/01105 (1986-02-01), None
patent: WO90/10462 (1990-09-01), None
patent: WO 90/10462 (1990-09-01), None
patent: WO 91/00731 (1991-01-01), None
patent: WO91/00731 (1991-01-01), None
patent: WO 91/00733 (1991-01-01), None
patent: WO91/00733 (1991-01-01), None
patent: WO 94/26767 (1994-11-01), None
patent: WO94/26767 (1994-11-01), None
patent: WO 96/26201 (1996-08-01), None
patent: WO96/26201 (1996-08-01), None
patent: WO 97/11162 (1997-03-01), None
patent: WO97/11162 (1997-03-01), None
patent: WO 99/46279 (1999-09-01), None
patent: WO99/46279 (1999-09-01), None
patent: WO9946279 (1999-09-01), None
patent: WO 03/022835 (2003-03-01), None
patent: WO 03/033487 (2003-04-01), None
patent: WO 2004/046111 (2004-06-01), None
Tsakovska, et al., “Molecular modeling of triazine type MDR modulators using CoMFA and CoMSIA approaches,” SAR and QSAR in Environmental Research, vol. 13, No. 3-4, pp. 487-498 (2002).
International Search Report of OC06001-01 (7 pgs).
Doll Ronald J.
Girijavallabhan Viyyoor
Guzi Timothy J.
Liu Yi-Tsung
Pachter Jonathan A.
Farquharson-Torres Serena
Freistein Andrew B.
Kalyanaraman Palaiyur S.
Schering Corporation
Shameem Golam M. M.
LandOfFree
17β-hydroxysteroid dehydrogenase type 3 inhibitors for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 17β-hydroxysteroid dehydrogenase type 3 inhibitors for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 17β-hydroxysteroid dehydrogenase type 3 inhibitors for... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3751649